Discovery of thirteen cobalt( ii ) and copper( ii ) salicylaldehyde Schiff base complexes that induce apoptosis and autophagy in human lung adenocarcinoma A549/DDP cells and that can overcome cisplatin resistance in vitro and in vivo
In this study, 13 transition metal complexes, namely, [Cu(L 1 H)(H 2 O) 2 ]·(H 2 O)·NO 3 (1), [Cu(L n H 2 ) 2 ]·(NO 3 )·(H 2 O) 2 (2, n = 2; 3, n = 3; 4, n = 4; 5, n = 5), [Co(L n H) 2 ] 2 ·(H 2 O) 0.5 (6, n = 2; 7, n = 3; 8, n = 4; 9, n = 5), [Cu(L 6 H) 0.5 (L 10 H) 0.5 (phen)]·(CH 3 OH) 0.25 (10),...
Saved in:
Published in | Dalton transactions : an international journal of inorganic chemistry Vol. 51; no. 10; pp. 4068 - 4078 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
England
Royal Society of Chemistry
08.03.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | In this study, 13 transition metal complexes, namely, [Cu(L
1
H)(H
2
O)
2
]·(H
2
O)·NO
3
(1), [Cu(L
n
H
2
)
2
]·(NO
3
)·(H
2
O)
2
(2,
n
= 2; 3,
n
= 3; 4,
n
= 4; 5,
n
= 5), [Co(L
n
H)
2
]
2
·(H
2
O)
0.5
(6,
n
= 2; 7,
n
= 3; 8,
n
= 4; 9,
n
= 5), [Cu(L
6
H)
0.5
(L
10
H)
0.5
(phen)]·(CH
3
OH)
0.25
(10), [Cu(L
11
H) (phen)]
4
·(H
2
O)
9
(11), [Cu(L
8
H)
0.27
(L
12
H)
0.73
(phen)]
4
·(H
2
O)
5.5
(CH
3
OH) (12), and [Cu(L
9
H) (phen)]
3
·(H
2
O)
7
·(CH
3
OH) (13), were synthesized using Schiff base ligands and characterized by elemental analysis (EA), infrared spectroscopy (IR), and single-crystal X-ray diffraction (SC-XRD). Compared with complexes 1–9, complexes 10–13 displayed stronger cytotoxic activities against the tested A549/DDP cancer cells (IC
50
= 0.97–3.31 μM), with differences greater than one order of magnitude. Moreover, complexes 11 and 13 could induce apoptosis and autophagy in A549/DDP cells
via
the mitochondrial dysfunction pathway that affects the regulation of autophagy- and mitochondrial-related proteins. Importantly, the results indicate that the two novel salicylaldehyde Schiff base analogs, 11 and 13, exhibited pronounced and selective activity against A549/DDP xenografts
in vivo
. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ISSN: | 1477-9226 1477-9234 1477-9234 |
DOI: | 10.1039/D1DT03749H |